Come up with a name for your new list and we'll add to it:
Quanterix raised a round of funding on June 14, 2017. Investors include
T. Rowe Price.
Quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. The Single Molecule Arra…